Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for alcohol craving reduction in alcohol use disorder
IRCT20211121053132N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol use disorder (AUD) comparing Pregabalin with Placebo pregabalin (2 arms). Primary endpoints: Effect of pregabalin on reducing craving to drink alcohol and Effect of pregabalin as a treatment for alcohol use disorder. Started Nov 2024; status: completed.
02
Drugs
pregabalin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on IRCT20211121053132N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211121053132N2.